{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:42:40Z","timestamp":1776087760943,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.amjms.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T14:42:47Z","timestamp":1613918567000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Apolipoprotein M Gene Polymorphism Rs805297 (C-1065A): Association With Type 2 Diabetes Mellitus and Related Microvascular Complications in South Egypt"],"prefix":"10.1016","volume":"362","author":[{"given":"Manal Mohammed","family":"Tageldeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosny","family":"Badrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Abdelmeguid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Zaghlol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eglal Mohamed","family":"Kenawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/j.amjms.2021.02.002_bib0001","doi-asserted-by":"crossref","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","article-title":"A novel human apolipoprotein (apoM)","volume":"274","author":"Xu","year":"1999","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.amjms.2021.02.002_bib0002","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1194\/jlr.M600055-JLR200","article-title":"Isolation and characterization of human apolipoprotein M-containing lipoproteins","volume":"47","author":"Christoffersen","year":"2006","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.amjms.2021.02.002_bib0003","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.3892\/mmr.2017.7831","article-title":"Apolipoprotein status in type 2 diabetes mellitus and its complications (Review)","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.amjms.2021.02.002_bib0004","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/1076029617730639","article-title":"Evaluation of expression level of apolipoprotein m as a diagnostic marker for primary venous thromboembolism","volume":"24","author":"Ahmad","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.amjms.2021.02.002_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2008.10.008","article-title":"Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes","volume":"42","author":"Wu","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.amjms.2021.02.002_bib0006","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2337\/diabetes.53.1.228","article-title":"Genome-wide search for type 2 diabetes\/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21\u2013q24","volume":"53","author":"Xiang","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.amjms.2021.02.002_bib0007","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/mmr.2015.3658","article-title":"Apolipoprotein M: research progress, regulation, and metabolic functions (Review)","volume":"12","author":"Huang","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.amjms.2021.02.002_bib0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dmrr.641","article-title":"Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese","volume":"23","author":"Niu","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.amjms.2021.02.002_bib0009","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12944-016-0307-3","article-title":"A single-nucleotide polymorphism C-724 \/del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus","volume":"15","author":"Zhang","year":"2016","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.amjms.2021.02.002_bib0010","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/diabetes.49.12.2201","article-title":"Parental transmission of type 2 diabetes: the Framingham offspring study","volume":"49","author":"Meigs","year":"2000","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.amjms.2021.02.002_bib0011","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.numecd.2014.05.007","article-title":"The association between apolipoprotein M and insulin resistance varies with country of birth","volume":"24","author":"Memon","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.amjms.2021.02.002_bib0012","doi-asserted-by":"crossref","first-page":"e17324","DOI":"10.1371\/journal.pone.0017324","article-title":"Apolipoprotein M Gene (APOM) Polymorphism modifies metabolic and disease traits in Type 2 diabetes","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.amjms.2021.02.002_bib0013","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.cca.2017.01.006","article-title":"ApoM\/HDLC and apoM\/apoAI ratios are indicators of nephropathy in healthy controls and type 2 diabetes mellitus","volume":"466","author":"Zhang","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.amjms.2021.02.002_bib0014","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2796.2009.02095.x","article-title":"Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects","author":"Plomgaard","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjms.2021.02.002_bib0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(01)02544-3","article-title":"Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis","volume":"499","author":"Duan","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.amjms.2021.02.002_bib0016","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1194\/jlr.M700113-JLR200","article-title":"An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma","volume":"48","author":"Axler","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.amjms.2021.02.002_bib0017","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.48.5.937","article-title":"Hyperglycemia and cardiovascular disease in type 2 diabetes","volume":"48","author":"Laakso","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.amjms.2021.02.002_bib0018","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/CIRCRESAHA.109.211086","article-title":"Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis","volume":"106","author":"Christoffersen","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.amjms.2021.02.002_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12944-017-0556-9","article-title":"Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome","volume":"16","author":"He","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.amjms.2021.02.002_bib0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1476-511X-12-184","article-title":"A single-nucleotide polymorphism in the proximal promoter region of the apolipoprotein M gene is associated with dyslipidaemia but not increased coronary artery diseases in Chinese populations","volume":"12","author":"Cao","year":"2013","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.amjms.2021.02.002_bib0021","doi-asserted-by":"crossref","unstructured":"Suastika K, Dwipayana P, Semadi MS and Kuswardhani TRA. Age is an Important Risk Factor for Type 2 Diabetes Mellitus and Cardiovascular Diseases, glucose tolerance. Open access peer-reviewed chapter. In: Chackrewarthy S (ed) InTech Open Access Publisher, 2012. DOI: 10.5772\/52397","DOI":"10.5772\/52397"},{"key":"10.1016\/j.amjms.2021.02.002_bib0022","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1758-5996-6-50","article-title":"The association of body mass index with the risk of type 2 diabetes: a case\u2013control study nested in an electronic health records system in the United States","volume":"6","author":"Ganz","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.amjms.2021.02.002_bib0023","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2337\/diacare.28.8.2013","article-title":"Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study","volume":"28","author":"Schmidt","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjms.2021.02.002_bib0024","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archinte.167.10.1068","article-title":"Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study","volume":"167","author":"Wilson","year":"2007","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.amjms.2021.02.002_bib0025","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.2337\/db14-1603","article-title":"Frikke-Schmidt R: HDL cholesterol and risk of type 2 diabetes: a Mendelian randomization study","volume":"64","author":"Haase","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.amjms.2021.02.002_bib0026","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCRESAHA.111.300581","article-title":"Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1","volume":"112","author":"Umemoto","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.amjms.2021.02.002_bib0027","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1172\/JCI41280","article-title":"An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells","volume":"120","author":"Sturek","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjms.2021.02.002_bib0028","doi-asserted-by":"crossref","DOI":"10.2337\/db19-0811","article-title":"Protection against insulin resistance by apolipoprotein M\/Sphingosine 1-Phosphate","author":"Kurano","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.amjms.2021.02.002_bib0029","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/381800a0","article-title":"Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate","volume":"381","author":"Cuvillier","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.amjms.2021.02.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaa2581","article-title":"HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation","volume":"8","author":"Galvani","year":"2015","journal-title":"Sci Signal"},{"key":"10.1016\/j.amjms.2021.02.002_bib0031","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1096\/fj.201500064","article-title":"Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1","volume":"30","author":"Christensen","year":"2016","journal-title":"FASEB J"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:15:29Z","timestamp":1762082129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0002962921000495"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.02.002","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein M Gene Polymorphism Rs805297 (C-1065A): Association With Type 2 Diabetes Mellitus and Related Microvascular Complications in South Egypt","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}